Nanomaterials 2011, 1(1), 31-63; doi:10.3390/nano1010031
Review

Functionalized Gold Nanoparticles and Their Biomedical Applications

email, email, email and * email
Received: 18 March 2011; in revised form: 3 June 2011 / Accepted: 8 June 2011 / Published: 14 June 2011
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Metal nanoparticles are being extensively used in various biomedical applications due to their small size to volume ratio and extensive thermal stability. Gold nanoparticles (GNPs) are an obvious choice due to their amenability of synthesis and functionalization, less toxicity and ease of detection. The present review focuses on various methods of functionalization of GNPs and their applications in biomedical research. Functionalization facilitates targeted delivery of these nanoparticles to various cell types, bioimaging, gene delivery, drug delivery and other therapeutic and diagnostic applications. This review is an amalgamation of recent advances in the field of functionalization of gold nanoparticles and their potential applications in the field of medicine and biology.
Keywords: gold nanoparticles; functionalization; drug delivery; gene delivery; biosensor; bioimaging
PDF Full-text Download PDF Full-Text [1051 KB, uploaded 14 June 2011 15:54 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Tiwari, P.M.; Vig, K.; Dennis, V.A.; Singh, S.R. Functionalized Gold Nanoparticles and Their Biomedical Applications. Nanomaterials 2011, 1, 31-63.

AMA Style

Tiwari PM, Vig K, Dennis VA, Singh SR. Functionalized Gold Nanoparticles and Their Biomedical Applications. Nanomaterials. 2011; 1(1):31-63.

Chicago/Turabian Style

Tiwari, Pooja M.; Vig, Komal; Dennis, Vida A.; Singh, Shree R. 2011. "Functionalized Gold Nanoparticles and Their Biomedical Applications." Nanomaterials 1, no. 1: 31-63.

Nanomaterials EISSN 2079-4991 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert